Trademark Overview
On Friday, September 12, 2025, a trademark application was filed for GENETIS with the United States Patent and Trademark Office. The USPTO has given the GENETIS trademark a serial number of 79435459. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, October 23, 2025. This trademark is owned by THERAVECTYS. The GENETIS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Vaccines for human or veterinary use; vaccines for human or veterinary, therapeutic or prophylactic use, based on lentiviral vectors; chemical, biological, pharmaceutical products and preparations for therapeutic, prophylactic, medical, pharmaceutical and veterinary use; chemical reagents for therapeutic, prophylactic, medical, pharmaceutical and veterinary use; chemical-pharmaceutical products for therapeutic, prophylactic, medical, pharmaceutical and veterinary use.
Scientific research and development services for medical, therapeutic, pharmaceutical, veterinary and biological purposes, in the therapeutic or prophylactic vaccination field based on lentiviruses; research and development of new biological and pharmaceutical products for therapeutic, medical and veterinary use, in the therapeutic or prophylactic vaccination field based on lentiviral vectors and immunotherapy; bacteriological research services; virology research; infectious disease research, oncology research, clinical trials of vaccines; research in the field of diagnostic and therapeutic products for the treatment of infectious diseases; research in the field of diagnostic and therapeutic products for the treatment of viral diseases and cancer.
